Copyright Reports & Markets. All rights reserved.

Global Insulin Pen and Pump Market Research Report 2021

Request for Sample of this report
Buy now

1 Insulin Pen and Pump Market Overview

  • 1.1 Product Overview and Scope of Insulin Pen and Pump
  • 1.2 Insulin Pen and Pump Segment by Type
    • 1.2.1 Global Insulin Pen and Pump Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Insulin Pens
    • 1.2.3 Insulin Pump
  • 1.3 Insulin Pen and Pump Segment by Application
    • 1.3.1 Insulin Pen and Pump Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital & Clinic
    • 1.3.3 Retail Pharmacy
    • 1.3.4 Online Sales
  • 1.4 Global Insulin Pen and Pump Market Size Estimates and Forecasts
    • 1.4.1 Global Insulin Pen and Pump Revenue 2016-2027
    • 1.4.2 Global Insulin Pen and Pump Sales 2016-2027
    • 1.4.3 Insulin Pen and Pump Market Size by Region: 2016 Versus 2021 Versus 2027

2 Insulin Pen and Pump Market Competition by Manufacturers

  • 2.1 Global Insulin Pen and Pump Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Insulin Pen and Pump Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Insulin Pen and Pump Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Insulin Pen and Pump Manufacturing Sites, Area Served, Product Type
  • 2.5 Insulin Pen and Pump Market Competitive Situation and Trends
    • 2.5.1 Insulin Pen and Pump Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Insulin Pen and Pump Players Market Share by Revenue
    • 2.5.3 Global Insulin Pen and Pump Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Insulin Pen and Pump Retrospective Market Scenario by Region

  • 3.1 Global Insulin Pen and Pump Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Insulin Pen and Pump Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Insulin Pen and Pump Market Facts & Figures by Country
    • 3.3.1 North America Insulin Pen and Pump Sales by Country
    • 3.3.2 North America Insulin Pen and Pump Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Insulin Pen and Pump Market Facts & Figures by Country
    • 3.4.1 Europe Insulin Pen and Pump Sales by Country
    • 3.4.2 Europe Insulin Pen and Pump Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Insulin Pen and Pump Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Insulin Pen and Pump Sales by Region
    • 3.5.2 Asia Pacific Insulin Pen and Pump Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Insulin Pen and Pump Market Facts & Figures by Country
    • 3.6.1 Latin America Insulin Pen and Pump Sales by Country
    • 3.6.2 Latin America Insulin Pen and Pump Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Insulin Pen and Pump Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Insulin Pen and Pump Sales by Country
    • 3.7.2 Middle East and Africa Insulin Pen and Pump Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Insulin Pen and Pump Historic Market Analysis by Type

  • 4.1 Global Insulin Pen and Pump Sales Market Share by Type (2016-2021)
  • 4.2 Global Insulin Pen and Pump Revenue Market Share by Type (2016-2021)
  • 4.3 Global Insulin Pen and Pump Price by Type (2016-2021)

5 Global Insulin Pen and Pump Historic Market Analysis by Application

  • 5.1 Global Insulin Pen and Pump Sales Market Share by Application (2016-2021)
  • 5.2 Global Insulin Pen and Pump Revenue Market Share by Application (2016-2021)
  • 5.3 Global Insulin Pen and Pump Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Novo Nordisk
    • 6.1.1 Novo Nordisk Corporation Information
    • 6.1.2 Novo Nordisk Description and Business Overview
    • 6.1.3 Novo Nordisk Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Novo Nordisk Product Portfolio
    • 6.1.5 Novo Nordisk Recent Developments/Updates
  • 6.2 Eli Lilly
    • 6.2.1 Eli Lilly Corporation Information
    • 6.2.2 Eli Lilly Description and Business Overview
    • 6.2.3 Eli Lilly Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Eli Lilly Product Portfolio
    • 6.2.5 Eli Lilly Recent Developments/Updates
  • 6.3 Sanofi
    • 6.3.1 Sanofi Corporation Information
    • 6.3.2 Sanofi Description and Business Overview
    • 6.3.3 Sanofi Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Sanofi Product Portfolio
    • 6.3.5 Sanofi Recent Developments/Updates
  • 6.4 BD
    • 6.4.1 BD Corporation Information
    • 6.4.2 BD Description and Business Overview
    • 6.4.3 BD Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 BD Product Portfolio
    • 6.4.5 BD Recent Developments/Updates
  • 6.5 Ypsomed Holding
    • 6.5.1 Ypsomed Holding Corporation Information
    • 6.5.2 Ypsomed Holding Description and Business Overview
    • 6.5.3 Ypsomed Holding Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Ypsomed Holding Product Portfolio
    • 6.5.5 Ypsomed Holding Recent Developments/Updates
  • 6.6 Dongbao
    • 6.6.1 Dongbao Corporation Information
    • 6.6.2 Dongbao Description and Business Overview
    • 6.6.3 Dongbao Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Dongbao Product Portfolio
    • 6.6.5 Dongbao Recent Developments/Updates
  • 6.7 Owen Mumford
    • 6.6.1 Owen Mumford Corporation Information
    • 6.6.2 Owen Mumford Description and Business Overview
    • 6.6.3 Owen Mumford Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Owen Mumford Product Portfolio
    • 6.7.5 Owen Mumford Recent Developments/Updates
  • 6.8 Ganlee
    • 6.8.1 Ganlee Corporation Information
    • 6.8.2 Ganlee Description and Business Overview
    • 6.8.3 Ganlee Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Ganlee Product Portfolio
    • 6.8.5 Ganlee Recent Developments/Updates
  • 6.9 Medtronic
    • 6.9.1 Medtronic Corporation Information
    • 6.9.2 Medtronic Description and Business Overview
    • 6.9.3 Medtronic Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Medtronic Product Portfolio
    • 6.9.5 Medtronic Recent Developments/Updates
  • 6.10 Roche
    • 6.10.1 Roche Corporation Information
    • 6.10.2 Roche Description and Business Overview
    • 6.10.3 Roche Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Roche Product Portfolio
    • 6.10.5 Roche Recent Developments/Updates
  • 6.11 Insulet Corp
    • 6.11.1 Insulet Corp Corporation Information
    • 6.11.2 Insulet Corp Insulin Pen and Pump Description and Business Overview
    • 6.11.3 Insulet Corp Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Insulet Corp Product Portfolio
    • 6.11.5 Insulet Corp Recent Developments/Updates
  • 6.12 Tandem Diabetes care
    • 6.12.1 Tandem Diabetes care Corporation Information
    • 6.12.2 Tandem Diabetes care Insulin Pen and Pump Description and Business Overview
    • 6.12.3 Tandem Diabetes care Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Tandem Diabetes care Product Portfolio
    • 6.12.5 Tandem Diabetes care Recent Developments/Updates
  • 6.13 Valeritas
    • 6.13.1 Valeritas Corporation Information
    • 6.13.2 Valeritas Insulin Pen and Pump Description and Business Overview
    • 6.13.3 Valeritas Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Valeritas Product Portfolio
    • 6.13.5 Valeritas Recent Developments/Updates
  • 6.14 SOOIL
    • 6.14.1 SOOIL Corporation Information
    • 6.14.2 SOOIL Insulin Pen and Pump Description and Business Overview
    • 6.14.3 SOOIL Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 SOOIL Product Portfolio
    • 6.14.5 SOOIL Recent Developments/Updates
  • 6.15 Microport
    • 6.15.1 Microport Corporation Information
    • 6.15.2 Microport Insulin Pen and Pump Description and Business Overview
    • 6.15.3 Microport Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Microport Product Portfolio
    • 6.15.5 Microport Recent Developments/Updates

7 Insulin Pen and Pump Manufacturing Cost Analysis

  • 7.1 Insulin Pen and Pump Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Insulin Pen and Pump
  • 7.4 Insulin Pen and Pump Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Insulin Pen and Pump Distributors List
  • 8.3 Insulin Pen and Pump Customers

9 Insulin Pen and Pump Market Dynamics

  • 9.1 Insulin Pen and Pump Industry Trends
  • 9.2 Insulin Pen and Pump Growth Drivers
  • 9.3 Insulin Pen and Pump Market Challenges
  • 9.4 Insulin Pen and Pump Market Restraints

10 Global Market Forecast

  • 10.1 Insulin Pen and Pump Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Insulin Pen and Pump by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Insulin Pen and Pump by Type (2022-2027)
  • 10.2 Insulin Pen and Pump Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Insulin Pen and Pump by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Insulin Pen and Pump by Application (2022-2027)
  • 10.3 Insulin Pen and Pump Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Insulin Pen and Pump by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Insulin Pen and Pump by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Insulin Pens
    Insulin Pump

    Segment by Application
    Hospital & Clinic
    Retail Pharmacy
    Online Sales

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Novo Nordisk
    Eli Lilly
    Sanofi
    BD
    Ypsomed Holding
    Dongbao
    Owen Mumford
    Ganlee
    Medtronic
    Roche
    Insulet Corp
    Tandem Diabetes care
    Valeritas
    SOOIL
    Microport

    Buy now